{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:57:18Z","timestamp":1790722638152,"version":"4.1.0"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatologie"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00105-026-05691-5","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:02:46Z","timestamp":1790719366000},"page":"20-22","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Alpha-Gal-Syndrom bei mikrozystischen Adnexkarzinom","Alpha-gal syndrome in microcystic adnexal carcinoma"],"prefix":"10.1007","volume":"77","author":[{"given":"Sophia","family":"Czell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surina","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Jakob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Charlotte","family":"Kuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Tomsitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Heinzerling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Flaig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva-Maria","family":"Oppel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"issue":"11","key":"5691_CR1","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1056\/NEJMoa074943","volume":"358","author":"CH Chung","year":"2008","unstructured":"Chung\u00a0CH, Mirakhur\u00a0B, Chan\u00a0E et\u00a0al (2008) Cetuximab-induced anaphylaxis and IgE specific for galactose-\u03b1\u20111,3\u2011galactose. N\u00a0Engl J Med 358(11):1109\u20131117","journal-title":"N Engl J Med"},{"key":"5691_CR2","volume":"44","author":"N Della Marta","year":"2025","unstructured":"Della Marta\u00a0N, Yuile\u00a0A, Mok\u00a0C et\u00a0al (2025) A protocol for pre-treatment testing for antibodies to galactose-alpha\u20111,3\u2011galactose to mitigate the risk of cetuximab hypersensitivity reactions - a retrospective cohort review. Cancer Treat Res Commun 44:100969","journal-title":"Cancer Treat Res Commun"},{"key":"5691_CR3","doi-asserted-by":"crossref","unstructured":"Kosztulska B, Rydzy\u0144ska M, Bartuzi Z, et\u00a0al. The expanding role of omalizumab: from food allergy to drug desensitization. Int J Mol Sci. 2025;26(16).","DOI":"10.3390\/ijms26167868"},{"issue":"5","key":"5691_CR4","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3949\/ccjm.92a.24072","volume":"92","author":"Z Naseem","year":"2025","unstructured":"Naseem\u00a0Z, Muhammad\u00a0A, Chatterjee\u00a0A, Rubio-Tapia\u00a0A (2025) Alpha-gal syndrome: recognizing and managing a tick-bite-related meat allergy. Cleve Clin J Med 92(5):311\u2013319","journal-title":"Cleve Clin J Med"},{"key":"5691_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1335911","volume":"15","author":"M Perusko","year":"2024","unstructured":"Perusko\u00a0M, Grundstr\u00f6m\u00a0J, Eldh\u00a0M, Hamsten\u00a0C, Apostolovic\u00a0D, van Hage\u00a0M (2024) The \u03b1\u2011Gal epitope \u2013 the cause of a global allergic disease. Front Immunol 15:1335911","journal-title":"Front Immunol"},{"issue":"1","key":"5691_CR6","volume":"332","author":"TAE Platts-Mills","year":"2025","unstructured":"Platts-Mills\u00a0TAE, Gangwar\u00a0RS, Workman\u00a0L, Wilson\u00a0JM (2025) The immunology of alpha-gal syndrome. Immunol Rev 332(1):e70035","journal-title":"Immunol Rev"}],"container-title":["Die Dermatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-026-05691-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-026-05691-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-026-05691-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:02:47Z","timestamp":1790719367000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-026-05691-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":6,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["5691"],"URL":"https:\/\/doi.org\/10.1007\/s00105-026-05691-5","relation":{},"ISSN":["2731-7005","2731-7013"],"issn-type":[{"value":"2731-7005","type":"print"},{"value":"2731-7013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"15 April 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.\u00a0Czell, S.\u00a0Frey, L.\u00a0Jakob, A.-C.\u00a0Kuna, D.\u00a0Tomsitz, L.\u00a0Heinzerling, M.J.\u00a0Flaig und E.-M.\u00a0Oppel geben an, dass kein Interessenkonflikt besteht.","order":1,"name":"Ethics","label":"Interessenkonflikt","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/-innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"This article is part of a\u00a0supplement sponsored by LEO Pharma GmbH","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}}]}}